Introduction
While mild thrombocytopenia is common in infectious mononucleosis (IM), severe thrombocytopenia is rare and troublesome haemorrhage is exceedingly rare, occurring in less than 0 05 % of cases (Sharp, 1969; Goldstein and Porter, 1969) . Mild thrombocytopenia without bleeding may persist for some weeks but does not require active measures. The natural history of severe thrombocytopenia, when it has occurred, has rarely been described because most recent records are complicated by the administration of steroids which are advocated in the management of thrombocytopenia in IM (Sharp, 1969; Goldstein and Porter, 1969; Weatherall and Bradley, 1974) . Lack of data on the natural history of severe thrombocytopenia in IM clearly makes judgement of the efficacy of any drug in its management difficult and the value of these agents in preventing serious haemorrhage in IM is consequently uncertain (Radel and Schorr, 1963 (Myatt and Linn, 1957; Grossman and Wolff, 1959) and there are reports of rises after steroids similar to or slower than those observed in the present patients (Krishnamurthy, Lee and Dosik, 1976; Clarke and Davies, 1964; Radel and Schorr, 1963) . Perhaps, had the present patients received continuous steroids, the rise in platelet count would have been faster; undoubtedly, had they received steroids and exhibited the spontaneous response recorded here, the authors would have attributed the response to the effect of the drugs.
More important than an effect of steroids on the platelet count, of course, is an effect in preventing dangerous haemorrhage. Here the influence of steroids in IM is unproved. There is anecdotal evidence that their use may reduce the time during which less serious haemorrhagic symptoms persist (Radel and Schorr, 1963) but fatal cerebral haemorrhage has occurred in IM despite steroid therapy (Goldstein and Porter, 1969 
